GW has only two products in the market with a market cap of over 3 Billions. The two products are for rare diseases. Zelira will have 15 products by the end of 2021 covering large markets like chronic pain and insomnia.
is it fair to compare the two ? Would love to hear everyone’s opinion?
Dream big with Zelira, page-712
-
- There are more pages in this discussion • 486 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.943M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 874 | 67.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.0¢ | 10 | 1 |
View Market Depth
| Last trade - 10.42am 01/11/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |
Day chart unavailable